Adjuvant radiotherapy ‘reduces mortality’ in pN1 prostate cancer
Researchers have quantified the survival benefit of adjuvant radiotherapy after radical prostatectomy compared with early salvage radiotherapy.
…
Tag: prostate cancer
Darolutamide ‘improves survival’ in hormone-sensitive prostate cancer
The ARASENS trial provides compelling evidence for adjunctive use of the drug with metastatic disease, researchers say.
Good sexual function post-prostatectomy linked to surgeon’s skill
US research shows some surgeons see 40% of their patients regain their former sexual function at 12 months, while others see none.
Treatment regret common among men with prostate cancer: study
Better support and education is needed so patients have realistic expectations, researchers say.
Acute urinary retention may be sign of cancer
Danish study shows excess risk for a number of cancers in men and women three month after an acute urinary retention diagnosis: BMJ.
Study casts doubt on prostate cancer therapy for COVID-19
Observational research shows survival in men with COVID-19 who are on androgen deprivation therapy is the same as those who aren't.
Hypofractionated radiotherapy following prostatectomy ‘non-inferior’
The higher dose but shorter duration approach has similar levels of side-effects to conventional dosing, US researchers say.
Should men with Lynch syndrome be screened for prostate cancer?
First results from the international IMPACT study suggest two pathogenic gene variants put carriers at increased risk.
Are two antiandrogens better than one in metastatic prostate cancer?
Final results of the ACIS study in patients with castration-resistant disease show a benefit in radiographic progression-free survival.
Metastatic prostate cancer subtypes ‘prognostic’
Researchers have demonstrated that patients with castration-resistant disease fall into luminal and basal subtypes and these respond differently to…
